Cargando…

Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain

INTRODUCTION: Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk–benefit and financial impact of immunizing their children against MenB in the absence of a natio...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinón-Torres, Federico, de Miguel, Ángel Gil, Ruiz-Contreras, Jesús, Vallejo-Aparicio, Laura A., García, Andrea, Gonzalez-Inchausti, María C., de Gomensoro, Eduardo, Kocaata, Zeki, Gabás-Rivera, Clara, Comellas, Marta, Prades, Miriam, Lizán, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868201/
https://www.ncbi.nlm.nih.gov/pubmed/36367677
http://dx.doi.org/10.1007/s40121-022-00708-7
_version_ 1784876481511424000
author Martinón-Torres, Federico
de Miguel, Ángel Gil
Ruiz-Contreras, Jesús
Vallejo-Aparicio, Laura A.
García, Andrea
Gonzalez-Inchausti, María C.
de Gomensoro, Eduardo
Kocaata, Zeki
Gabás-Rivera, Clara
Comellas, Marta
Prades, Miriam
Lizán, Luis
author_facet Martinón-Torres, Federico
de Miguel, Ángel Gil
Ruiz-Contreras, Jesús
Vallejo-Aparicio, Laura A.
García, Andrea
Gonzalez-Inchausti, María C.
de Gomensoro, Eduardo
Kocaata, Zeki
Gabás-Rivera, Clara
Comellas, Marta
Prades, Miriam
Lizán, Luis
author_sort Martinón-Torres, Federico
collection PubMed
description INTRODUCTION: Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk–benefit and financial impact of immunizing their children against MenB in the absence of a national immunization program (NIP). This study aimed to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain. METHODS: A discrete choice experiment (DCE) based on cross-sectional surveys was carried out to determine preferences. A literature review and scientific committee determined the six attributes related to the MenB vaccine included in the DCE: vaccination age, cost, duration, percentage of protection, adverse events probability, and expert/authority recommendation. Data were analyzed using a mixed logit model. Relative importance (RI) of attributes was calculated and compared between parents and pediatricians. RESULTS: A total of 278 parents [55.8% female, mean age 40.4 (standard deviation, SD 7.3) years] and 200 pediatricians [73.0% female, mean age 45.8 (SD 12.9) years] answered the DCE. For parents, the highest RI was attributed to vaccine cost, expert/authority recommendation, and percentage of protection (26.4%, 26.1%, and 22.9%, respectively), while for pediatricians the highest RI was assigned to percentage of protection, expert/authority recommendation, and vaccination age (27.2%, 23.7%, and 22.6%, respectively). Significant differences between parents and pediatricians were found in the RI assigned to all attributes (p < 0.001), except for vaccine recommendation. CONCLUSION: In the decision regarding MenB vaccination, cost was a driver in parental decision-making but had a low RI for pediatricians and, conversely, vaccination age was highly valued by pediatricians but was the attribute with least importance for parents. Despite these differences, expert/authority recommendation and percentage of protection were essential criteria for both groups. These results provide relevant information about MenB vaccination, highlighting the importance of considering societal preferences for NIP inclusion. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-022-00708-7.
format Online
Article
Text
id pubmed-9868201
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-98682012023-01-24 Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain Martinón-Torres, Federico de Miguel, Ángel Gil Ruiz-Contreras, Jesús Vallejo-Aparicio, Laura A. García, Andrea Gonzalez-Inchausti, María C. de Gomensoro, Eduardo Kocaata, Zeki Gabás-Rivera, Clara Comellas, Marta Prades, Miriam Lizán, Luis Infect Dis Ther Original Research INTRODUCTION: Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk–benefit and financial impact of immunizing their children against MenB in the absence of a national immunization program (NIP). This study aimed to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain. METHODS: A discrete choice experiment (DCE) based on cross-sectional surveys was carried out to determine preferences. A literature review and scientific committee determined the six attributes related to the MenB vaccine included in the DCE: vaccination age, cost, duration, percentage of protection, adverse events probability, and expert/authority recommendation. Data were analyzed using a mixed logit model. Relative importance (RI) of attributes was calculated and compared between parents and pediatricians. RESULTS: A total of 278 parents [55.8% female, mean age 40.4 (standard deviation, SD 7.3) years] and 200 pediatricians [73.0% female, mean age 45.8 (SD 12.9) years] answered the DCE. For parents, the highest RI was attributed to vaccine cost, expert/authority recommendation, and percentage of protection (26.4%, 26.1%, and 22.9%, respectively), while for pediatricians the highest RI was assigned to percentage of protection, expert/authority recommendation, and vaccination age (27.2%, 23.7%, and 22.6%, respectively). Significant differences between parents and pediatricians were found in the RI assigned to all attributes (p < 0.001), except for vaccine recommendation. CONCLUSION: In the decision regarding MenB vaccination, cost was a driver in parental decision-making but had a low RI for pediatricians and, conversely, vaccination age was highly valued by pediatricians but was the attribute with least importance for parents. Despite these differences, expert/authority recommendation and percentage of protection were essential criteria for both groups. These results provide relevant information about MenB vaccination, highlighting the importance of considering societal preferences for NIP inclusion. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-022-00708-7. Springer Healthcare 2022-11-11 2023-01 /pmc/articles/PMC9868201/ /pubmed/36367677 http://dx.doi.org/10.1007/s40121-022-00708-7 Text en © GSK 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Martinón-Torres, Federico
de Miguel, Ángel Gil
Ruiz-Contreras, Jesús
Vallejo-Aparicio, Laura A.
García, Andrea
Gonzalez-Inchausti, María C.
de Gomensoro, Eduardo
Kocaata, Zeki
Gabás-Rivera, Clara
Comellas, Marta
Prades, Miriam
Lizán, Luis
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
title Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
title_full Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
title_fullStr Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
title_full_unstemmed Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
title_short Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
title_sort societal preferences for meningococcal b vaccination in children: a discrete choice experiment in spain
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868201/
https://www.ncbi.nlm.nih.gov/pubmed/36367677
http://dx.doi.org/10.1007/s40121-022-00708-7
work_keys_str_mv AT martinontorresfederico societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT demiguelangelgil societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT ruizcontrerasjesus societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT vallejoapariciolauraa societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT garciaandrea societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT gonzalezinchaustimariac societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT degomensoroeduardo societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT kocaatazeki societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT gabasriveraclara societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT comellasmarta societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT pradesmiriam societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain
AT lizanluis societalpreferencesformeningococcalbvaccinationinchildrenadiscretechoiceexperimentinspain